RJA
TECH icon

Ross\Johnson & Associates’s Bio-Techne TECH Stock Holding History

Ross\Johnson & Associates’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Hold
63
– – 0.07% 53
2026
Q1 		$3.29K Hold
63
– – 0.06% 57
2025
Q4 		$3.71K Sell
63
-1
-2% -$61 0.07% 56
2025
Q3 		$3.56K Hold
64
– – 0.07% 57
2025
Q2 		$3.29K Hold
64
– – 0.07% 51
2025
Q1 		$3.75K Hold
64
– – 0.06% 106
2024
Q4 		$4.61K Buy
+64
New +$4.7K 0.11% 48

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ross\Johnson & Associates's TECH Position: Q2 2026 in Review

Ross\Johnson & Associates held its Bio-Techne (TECH) position steady in Q2 2026 at 63 shares worth $4.45K. The position accounts for 0.07% of the portfolio, ranked #53.

Ross\Johnson & Associates first reported a position in TECH in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.61K in Q4 2024. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Ross\Johnson & Associates held 63 shares of Bio-Techne worth $4.45K as of Q2 2026.
  • Ross\Johnson & Associates left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up 0.07% of Ross\Johnson & Associates's portfolio in Q2 2026, its #53 holding.
  • Ross\Johnson & Associates first reported a position in Bio-Techne in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Bio-Techne position peaked at $4.61K in Q4 2024.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.